GDRX stock

Goodrx Holdings Inc (GDRX) stock news · P/E 56, rev $796.9M

Goodrx Holdings Inc (GDRX) is a health information services company listed on US.

This GDRX news page leads with what Goodrx Holdings Inc filed — not a scraped headline mill.

No cached 8-K sentence for GDRX yet. We will not pad this page with generic market recap.

Latest reported GDRX revenue for 2025-12-31 was $796.9M. Net income was $30.4M. Revenue was up 0.6% from 2024-12-31 to 2025-12-31. GDRX currently screens at market cap $988.9M and trailing P/E 56.0.

EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.

Not investment advice. For the model open the GDRX stock page; for the tape open the quote page.

GDRX stock news FAQ

What are GDRX's latest revenue and net income?

Latest cached Goodrx Holdings Inc (GDRX) revenue for Dec 31, 2025 was $796.9M. Net income was $30.4M. Statements: https://lician.com/financials/gdrx

How did GDRX revenue change from the prior cached period?

Cached Goodrx Holdings Inc (GDRX) revenue was up 0.6% from $792.3M (Dec 31, 2024) to $796.9M (Dec 31, 2025). Statements: https://lician.com/financials/gdrx

What is GDRX's P/E ratio?

Goodrx Holdings Inc (GDRX) trailing P/E is 56.0 on the latest cached fundamentals snapshot.

What is GDRX's market cap?

Goodrx Holdings Inc (GDRX) market cap is $988.9M on the latest cached fundamentals snapshot.

What kind of company is GDRX?

Goodrx Holdings Inc (GDRX) is a health information services company listed on US.

Where is GDRX stock news listed?

Cached stock news for Goodrx Holdings Inc (GDRX) is listed at https://lician.com/news/gdrx. Filings: https://lician.com/sec/gdrx

Not investment advice.

Full GDRX analysis